Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Oct. 02, 2015 | Oct. 30, 2015 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Oct. 2, 2015 | |
Document Fiscal Year Focus | 2,015 | |
Document Fiscal Period Focus | Q3 | |
Entity Registrant Name | EXPONENT INC | |
Entity Central Index Key | 851,520 | |
Current Fiscal Year End Date | --01-01 | |
Entity Filer Category | Large Accelerated Filer | |
Trading Symbol | EXPO | |
Entity Common Stock, Shares Outstanding | 25,746,928 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 |
Current assets: | ||
Cash and cash equivalents | $ 124,457 | $ 129,490 |
Short-term investments | 26,837 | 24,913 |
Accounts receivable, net of allowance for doubtful accounts and contract losses of $3,340 and $3,386 at October 2, 2015 and January 2, 2015, respectively | 94,168 | 86,368 |
Prepaid expenses and other assets | 12,884 | 14,727 |
Deferred income taxes | 11,112 | 11,002 |
Total current assets | 269,458 | 266,500 |
Property, equipment and leasehold improvements, net | 29,390 | 28,264 |
Goodwill | 8,607 | 8,607 |
Deferred income taxes | 25,336 | 24,612 |
Deferred compensation plan assets | 34,960 | 36,195 |
Other assets | 1,230 | 1,121 |
Total assets | 368,981 | 365,299 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 8,945 | 8,935 |
Accrued payroll and employee benefits | 54,726 | 62,184 |
Deferred revenues | 5,892 | 8,226 |
Total current liabilities | 69,563 | 79,345 |
Other liabilities | 1,936 | 1,862 |
Deferred compensation | 38,714 | 37,745 |
Deferred rent | 1,979 | 2,059 |
Total liabilities | 112,192 | 121,011 |
Stockholders' equity: | ||
Common stock, $0.001 par value; 80,000 shares authorized; 32,853 shares issued at October 2, 2015 and January 2, 2015 | 33 | 33 |
Additional paid-in capital | 177,129 | 160,208 |
Accumulated other comprehensive income | ||
Investment securities, available-for-sale | 10 | 14 |
Foreign currency translation adjustments | (1,453) | (918) |
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total | (1,443) | (904) |
Retained earnings | 263,417 | 246,961 |
Treasury stock, at cost; 7,172 and 7,111 shares held at October 2, 2015 and January 2, 2015, respectively | (182,347) | (162,010) |
Total stockholders' equity | 256,789 | 244,288 |
Total liabilities and stockholders' equity | $ 368,981 | $ 365,299 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 |
Accounts receivable, allowance for contract losses and doubtful accounts | $ 3,340 | $ 3,386 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 80,000 | 80,000 |
Common stock, shares issued | 32,853 | 32,853 |
Treasury stock, shares | 7,172 | 7,111 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | |
Revenues: | ||||
Revenues before reimbursements | $ 74,503 | $ 74,264 | $ 225,916 | $ 219,562 |
Reimbursements | 4,491 | 4,293 | 13,235 | 11,531 |
Revenues | 78,994 | 78,557 | 239,151 | 231,093 |
Operating expenses: | ||||
Compensation and related expenses | 42,853 | 43,948 | 139,745 | 138,855 |
Other operating expenses | 6,766 | 6,715 | 19,979 | 19,482 |
Reimbursable expenses | 4,491 | 4,293 | 13,235 | 11,531 |
General and administrative expenses | 3,963 | 4,363 | 11,538 | 11,809 |
Total operating expenses | 58,073 | 59,319 | 184,497 | 181,677 |
Operating income | 20,921 | 19,238 | 54,654 | 49,416 |
Other income, net: | ||||
Interest income, net | 47 | 33 | 115 | 117 |
Miscellaneous income, net | (2,195) | (896) | 367 | 2,605 |
Total other income, net | (2,148) | (863) | 482 | 2,722 |
Income before income taxes | 18,773 | 18,375 | 55,136 | 52,138 |
Income taxes | 7,054 | 7,335 | 21,387 | 20,680 |
Net income | $ 11,719 | $ 11,040 | $ 33,749 | $ 31,458 |
Net income per share: | ||||
Basic | $ 0.44 | $ 0.41 | $ 1.27 | $ 1.16 |
Diluted | $ 0.43 | $ 0.40 | $ 1.23 | $ 1.13 |
Shares used in per share computations: | ||||
Basic | 26,597 | 26,938 | 26,644 | 27,018 |
Diluted | 27,268 | 27,648 | 27,350 | 27,778 |
Cash dividends declared per common share | $ 0.150 | $ 0.125 | $ 0.450 | $ 0.375 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | |
Net income | $ 11,719 | $ 11,040 | $ 33,749 | $ 31,458 |
Other comprehensive income (loss): | ||||
Foreign currency translation adjustments, net of tax | (199) | (840) | (535) | (471) |
Unrealized gains (losses) on available-for- sale investment securities arising during the period, net of tax | 13 | (13) | (4) | 9 |
Comprehensive income | $ 11,533 | $ 10,187 | $ 33,210 | $ 30,996 |
Condensed Consolidated Stateme6
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Oct. 02, 2015 | Oct. 03, 2014 | |
Cash flows from operating activities: | ||
Net income | $ 33,749 | $ 31,458 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization of property, equipment and leasehold improvements | 4,034 | 3,979 |
Amortization of premiums and accretion of discounts on short-term investments | 515 | 660 |
Deferred rent | (80) | (170) |
Provision for doubtful accounts and contract losses | 785 | 1,234 |
Stock-based compensation | 10,536 | 10,585 |
Deferred income tax provision | (869) | (6,046) |
Excess tax benefit from equity incentive plans | (4,983) | (5,126) |
Changes in operating assets and liabilities: | ||
Accounts receivable | (8,585) | (13,343) |
Prepaid expenses and other assets | 1,206 | (2,877) |
Accounts payable and accrued liabilities | 4,236 | 6,314 |
Accrued payroll and employee benefits | (3,900) | 331 |
Deferred revenues | (2,334) | (923) |
Net cash provided by operating activities | 34,310 | 26,076 |
Cash flows from investing activities: | ||
Capital expenditures | (4,355) | (3,906) |
Purchase of short-term investments | (16,000) | (1,067) |
Maturity of short-term investments | 13,555 | 7,586 |
Net cash (used in) provided by investing activities | (6,800) | 2,613 |
Cash flows from financing activities: | ||
Excess tax benefit from equity incentive plans | 4,983 | 5,126 |
Payroll taxes for restricted stock units | (7,365) | (6,356) |
Repurchase of common stock | (19,814) | (26,372) |
Exercise of share-based payment awards | 1,547 | 1,811 |
Dividends and dividend equivalents rights | (11,780) | (9,842) |
Net cash used in financing activities | (32,429) | (35,633) |
Effect of foreign currency exchange rates on cash and cash equivalents | (114) | (390) |
Net decrease in cash and cash equivalents | (5,033) | (7,334) |
Cash and cash equivalents at beginning of period | 129,490 | 122,948 |
Cash and cash equivalents at end of period | $ 124,457 | $ 115,614 |
Basis of Presentation
Basis of Presentation | 9 Months Ended |
Oct. 02, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Note 1: Basis of Presentation Exponent, Inc. (referred to as the “Company” or “Exponent”) is an engineering and scientific consulting firm that provides solutions to complex problems. The Company operates on a 52-53 week fiscal year ending on the Friday closest to the last day of December. The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not contain all the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments which are necessary for the fair presentation of the condensed consolidated financial statements have been included and all such adjustments are of a normal and recurring nature. The operating results for the three and nine months ended October 2, 2015 are not necessarily representative of the results of future quarterly or annual periods. The following information should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 2, 2015 which was filed with the U.S. Securities and Exchange Commission on March 2, 2015. The unaudited condensed consolidated financial statements include the accounts of Exponent, Inc. and its subsidiaries, which are all wholly owned. All intercompany accounts and transactions have been eliminated in consolidation. Stock Split. On May 28, 2015, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to (i) amend the number of authorized shares of common stock to 80,000,000 2,000,000 two-for-one stock split Dividend. Fiscal Year 2015 Dividends Amount Per Share (in thousands) First Quarter $ 0.150 $ 3,858 Second Quarter $ 0.150 $ 3,887 Third Quarter $ 0.150 $ 3,870 $ 11,615 Fiscal Year 2014 Dividends Amount Per Share (in thousands) First Quarter $ 0.125 $ 3,262 Second Quarter $ 0.125 3,270 Third Quarter $ 0.125 3,262 Fourth Quarter $ 0.125 3,216 $ 13,010 On October 21, 2015 the Company’s Board of Directors announced a cash dividend of $ 0.15 Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for doubtful accounts and contract losses. Actual results could differ from those estimates. Recently Adopted Accounting Pronouncements. On May 28, 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, Revenue from Contracts with Customers |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Oct. 02, 2015 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 2: Fair Value Measurements The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There have been no transfers between fair value measurement levels during the nine months ended October 2, 2015 and October 3, 2014. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 3,608 $ 3,608 $ - $ - Fixed income available- for-sale securities (2) 26,837 - 26,837 - Fixed income trading securities held in deferred compensation plan (3) 9,007 9,007 - - Equity trading securities held in deferred compensation plan (3) 32,277 32,277 - - Total $ 71,729 $ 44,892 $ 26,837 $ - Liabilities Deferred compensation plan (4) 45,038 45,038 - - Total $ 45,038 $ 45,038 $ - $ - ( Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. (2) Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet. The fair value of these certain financial assets and liabilities was determined using the following inputs at January 2, 2015: Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 45,478 $ 45,478 $ - $ - Fixed income available- for-sale securities (2) 24,913 - 24,913 - Fixed income trading securities held in deferred compensation plan (3) 9,672 9,672 - - Equity trading securities held in deferred compensation plan (3) 34,176 34,176 - - Total $ 114,239 $ 89,326 $ 24,913 $ - Liabilities Deferred compensation plan (4) 45,394 45,394 - - Total $ 45,394 $ 45,394 $ - $ - (1) Included in cash and cash equivalents on the Company’s consolidated balance sheet. (2) Included in short-term investments on the Company’s consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s consolidated balance sheet. Fixed income available-for-sale securities as of October 2, 2015 and January 2, 2015 represent obligations of state and local government agencies and United States agencies. Fixed income and equity trading securities represent mutual funds held in the Company’s deferred compensation plan. See Note 6 for additional information about the Company’s deferred compensation plan. sh, cash equivalents and short -term investments consisted of the following as of October 2, 2015: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 120,849 $ - $ - $ 120,849 Cash equivalents: Money market securities 3,608 - - 3,608 Total cash equivalents 3,608 - - 3,608 Total cash and cash equivalents 124,457 - - 124,457 Short-term investments: U.S. agency securities 16,000 14 - 16,014 State and municipal bonds 10,821 3 (1) 10,823 Total short-term investments 26,821 17 (1) 26,837 Total cash, cash equivalents and short-term investments $ 151,278 $ 17 $ (1) $ 151,294 Cash, cash equivalents and short-term investments consisted of the following as of January 2, 2015: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 84,012 $ - $ - $ 84,012 Cash equivalents: Money market securities 45,478 - - 45,478 Total cash equivalents 45,478 - - 45,478 Total cash and cash equivalents 129,490 - - 129,490 Short-term investments: State and municipal bonds 24,890 27 (4) 24,913 Total short-term investments 24,890 27 (4) 24,913 Total cash, cash equivalents and short-term investments $ 154,380 $ 27 $ (4) $ 154,403 Amortized Estimated (In thousands) Cost Fair Value Due within one year $ 10,821 $ 10,823 Due between one and two years 16,000 16,014 Total $ 26,821 $ 26,837 At October 2, 2015 and January 2, 2015, the Company did not have any assets or liabilities valued using significant unobservable inputs. The following financial instruments are not measured at fair value on the Company's consolidated balance sheet at October 2, 2015 and January 2, 2015, but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at October 2, 2015 and January 2, 2015 approximates their carrying value as reported on the consolidated balance sheet. There were no other-than-temporary impairments or credit losses related to available -for-sale securities during the three and nine months ended October 2, 2015 and October 3, 2014. |
Net Income Per Share
Net Income Per Share | 9 Months Ended |
Oct. 02, 2015 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | Note 3: Net Income Per Share Basic per share amounts are computed using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the period and, when dilutive, the weighted-average number of potential common shares from the issuance of common stock to satisfy outstanding restricted stock units and the exercise of outstanding options to purchase common stock using the treasury stock method. Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, (In thousands) 2015 2014 2015 2014 Shares used in basic per share computation 26,597 26,938 26,644 27,018 Effect of dilutive common stock options outstanding 139 118 143 138 Effect of dilutive restricted stock units outstanding 532 592 563 622 Shares used in diluted per share computation 27,268 27,648 27,350 27,778 Common stock options to purchase 40,000 44.20 33,993 44.20 |
Stock-Based Compensation
Stock-Based Compensation | 9 Months Ended |
Oct. 02, 2015 | |
Share-Based Compensation [Abstract] | |
Stock-Based Compensation | Note 4: Stock-Based Compensation Restricted Stock Units Restricted stock unit grants are designed to attract and retain employees, and to better align employee interests with those of the Company’s stockholders. For a select group of employees, up to 40 The value of these restricted stock unit awards is determined based on the market price of the Company’s common stock on the date of grant. The value of fully vested restricted stock unit awards issued is recorded as a reduction to accrued bonuses. The portion of bonus expense that the Company expects to settle with fully vested restricted stock unit awards is recorded as stock-based compensation during the period the bonus is earned. The Company recorded stock-based compensation expense associated with accrued bonus awards of $ 1,616,000 1,657,000 4,959,000 4,825,000 967,000 982,000 5,078,000 5,145,000 Stock Options Stock options are granted for terms of ten years and generally vest 25% per year over a four-year period from the grant date. Unvested stock option awards will continue to vest in the case of retirement at 59½ years or older, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company. The Company grants options at exercise prices equal to the fair value of the Company’s common stock on the date of grant. The Company recorded stock-based compensation expense associated with stock option grants of $ 51,000 71,000 The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The determination of the fair value of stock option awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends. The Company used historical exercise and post-vesting forfeiture and expiration data to estimate the expected term of options granted. The historical volatility of the Company’s common stock over a period of time equal to the expected term of the options granted was used to estimate expected volatility. The risk-free interest rate used in the option-pricing model was based on United States Treasury zero-coupon issues with remaining terms similar to the expected term on the options. The Company is required to estimate forfeitures at the time of grant and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Historical data was used to estimate pre-vesting option forfeitures and stock-based compensation expense was recorded only for those awards that are expected to vest. All stock-based payment awards are recognized on a straight-line basis over the requisite service periods of the awards. |
Treasury Stock
Treasury Stock | 9 Months Ended |
Oct. 02, 2015 | |
Equity [Abstract] | |
Treasury Stock | Note 5: Treasury Stock On February 9, 2012, the Company’s Board of Directors authorized $ 35,000,000 35,000,000 35,000,000 The Company repurchased 463,402 19,814,000 767,278 27,923,000 15,265,000 Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $ 4,943,000 6,050,000 |
Deferred Compensation Plans
Deferred Compensation Plans | 9 Months Ended |
Oct. 02, 2015 | |
Deferred Compensation Arrangements [Abstract] | |
Deferred Compensation Plan | Note 6: Deferred Compensation Plans The Company maintains nonqualified deferred compensation plans for the benefit of a select group of highly compensated employees. Under these plans, participants may elect to defer up to 100 41,284,000 43,848,000 These assets are classified as trading securities and are recorded at fair value with changes recorded as adjustments to miscellaneous income, net. As of October 2, 2015 and January 2, 2015, vested amounts due under the plans totaled $ 45,038,000 45,394,000 2,688,000 1,331,000 miscellaneous income, net 1,351,000 miscellaneous |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 9 Months Ended |
Oct. 02, 2015 | |
Supplemental Cash Flow Information [Abstract] | |
Supplemental Cash Flow Information | Note 7: Supplemental Cash Flow Information Nine Months Ended October 2, October 3, (In thousands) 2015 2014 Cash paid during period: Income taxes $ 17,087 $ 17,458 Non-cash investing and financing activities: Unrealized (loss) gain on short-term investments $ (4) $ 9 Vested stock unit awards issued to settle accrued bonuses $ 6,169 $ 6,008 Accrual for capital expenditures $ 805 $ 164 Stock repurchases payable to broker $ - $ 1,551 |
Accounts Receivable, Net
Accounts Receivable, Net | 9 Months Ended |
Oct. 02, 2015 | |
Receivables [Abstract] | |
Accounts Receivable, Net | Note 8: Accounts Receivable, Net At October 2, 2015 and January 2, 2015, accounts receivable, net, was comprised of the following: October 2, January 2, (In thousands) 2015 2015 Billed accounts receivable $ 61,722 $ 63,331 Unbilled accounts receivable 35,786 26,423 Allowance for doubtful accounts and contract losses (3,340) (3,386) Total accounts receivable, net $ 94,168 $ 86,368 |
Segment Reporting
Segment Reporting | 9 Months Ended |
Oct. 02, 2015 | |
Disclosure Segment Information [Abstract] | |
Segment Reporting | Segment inform ation for the three and nine months ended October 2, 2015 and October 3, 2014 follows: Revenues Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, (In thousands) 2015 2014 2015 2014 Engineering and Other Scientific $ 61,052 $ 57,491 $ 180,212 $ 168,611 Environmental and Health 17,942 21,066 58,939 62,482 Total revenues $ 78,994 $ 78,557 $ 239,151 $ 231,093 Operating Income Three Months Ended Nine Months Ended (In thousands) October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Engineering and Other Scientific $ 20,252 $ 18,939 $ 58,605 $ 55,457 Environmental and Health 5,039 7,007 18,134 20,171 Total segment operating income 25,291 25,946 76,739 75,628 Corporate operating expense (4,370) (6,708) (22,085) (26,212) Total operating income $ 20,921 $ 19,238 $ 54,654 $ 49,416 Capital Expenditures Three Months Ended Nine Months Ended (In thousands) October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Engineering and Other Scientific $ 1,057 $ 1,509 $ 2,268 $ 2,833 Environmental and Health 52 36 123 151 Total segment capital expenditures 1,109 1,545 2,391 2,984 Corporate capital expenditures 1,532 385 1,964 922 Total capital expenditures $ 2,641 $ 1,930 $ 4,355 $ 3,906 Depreciation and Amortization Three Months Ended Nine Months Ended (In thousands) October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Engineering and Other Scientific $ 951 $ 923 $ 2,877 $ 2,664 Environmental and Health 46 49 133 145 Total segment depreciation and amortization 997 972 3,010 2,809 Corporate depreciation and amortization 332 374 1,024 1,170 Total depreciation and amortization $ 1,329 $ 1,346 $ 4,034 $ 3,979 |
Goodwill
Goodwill | 9 Months Ended |
Oct. 02, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | Note 10: Goodwill Environmental Engineering and (In thousands) and Health Other Scientific Total Goodwill $ 8,099 $ 508 $ 8,607 There were no acquisitions, dispositions, impairments or other changes in the carrying amount of goodwill, nor any changes in the composition of the Company’s reporting units, during the three and nine months ended October 2, 2015. |
Contingencies
Contingencies | 9 Months Ended |
Oct. 02, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | Note 11: Contingencies The Company is a party to various legal actions from time to time and may be contingently liable in connection with claims and contracts arising in the normal course of business, the outcome of which the Company believes, after consultation with legal counsel, will not have a material adverse effect on its financial condition, results of operations or liquidity. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results. All legal costs associated with litigation are expensed as incurred. |
Subsequent Event
Subsequent Event | 9 Months Ended |
Oct. 02, 2015 | |
Subsequent Events [Abstract] | |
Subsequent Event | Note 12: Subsequent Event On October 21, 2015, the Company announced that its Board of Directors had authorized an additional $ 35,000,000 50,000,000 |
Basis of Presentation (Tables)
Basis of Presentation (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Common Stock Dividends Declared Per Share | The Company declared and paid cash dividends per common share during the periods presented as follows: Fiscal Year 2015 Dividends Amount Per Share (in thousands) First Quarter $ 0.150 $ 3,858 Second Quarter $ 0.150 $ 3,887 Third Quarter $ 0.150 $ 3,870 $ 11,615 Fiscal Year 2014 Dividends Amount Per Share (in thousands) First Quarter $ 0.125 $ 3,262 Second Quarter $ 0.125 3,270 Third Quarter $ 0.125 3,262 Fourth Quarter $ 0.125 3,216 $ 13,010 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Fair Value Disclosures [Abstract] | |
Assets and Liabilities Measured at Fair Value on Recurring Basis | The fair value of these certain financial assets and liabilities was determined using the following inputs at October 2, 2015: Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 3,608 $ 3,608 $ - $ - Fixed income available- for-sale securities (2) 26,837 - 26,837 - Fixed income trading securities held in deferred compensation plan (3) 9,007 9,007 - - Equity trading securities held in deferred compensation plan (3) 32,277 32,277 - - Total $ 71,729 $ 44,892 $ 26,837 $ - Liabilities Deferred compensation plan (4) 45,038 45,038 - - Total $ 45,038 $ 45,038 $ - $ - ( Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. (2) Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet. The fair value of these certain financial assets and liabilities was determined using the following inputs at January 2, 2015: Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 45,478 $ 45,478 $ - $ - Fixed income available- for-sale securities (2) 24,913 - 24,913 - Fixed income trading securities held in deferred compensation plan (3) 9,672 9,672 - - Equity trading securities held in deferred compensation plan (3) 34,176 34,176 - - Total $ 114,239 $ 89,326 $ 24,913 $ - Liabilities Deferred compensation plan (4) 45,394 45,394 - - Total $ 45,394 $ 45,394 $ - $ - (1) Included in cash and cash equivalents on the Company’s consolidated balance sheet. (2) Included in short-term investments on the Company’s consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s consolidated balance sheet. |
Cash, cash equivalents and short-term investments | Ca sh, cash equivalents and short -term investments consisted of the following as of October 2, 2015: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 120,849 $ - $ - $ 120,849 Cash equivalents: Money market securities 3,608 - - 3,608 Total cash equivalents 3,608 - - 3,608 Total cash and cash equivalents 124,457 - - 124,457 Short-term investments: U.S. agency securities 16,000 14 - 16,014 State and municipal bonds 10,821 3 (1) 10,823 Total short-term investments 26,821 17 (1) 26,837 Total cash, cash equivalents and short-term investments $ 151,278 $ 17 $ (1) $ 151,294 Cash, cash equivalents and short-term investments consisted of the following as of January 2, 2015: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 84,012 $ - $ - $ 84,012 Cash equivalents: Money market securities 45,478 - - 45,478 Total cash equivalents 45,478 - - 45,478 Total cash and cash equivalents 129,490 - - 129,490 Short-term investments: State and municipal bonds 24,890 27 (4) 24,913 Total short-term investments 24,890 27 (4) 24,913 Total cash, cash equivalents and short-term investments $ 154,380 $ 27 $ (4) $ 154,403 |
Summary of Cost and Estimated Fair Value of Short Term Fixed Income Securities | The following table summarizes the cost and estimated fair value of short-term fixed income securities classified as short-term investments based on stated effective maturities as of October 2, 2015: Amortized Estimated (In thousands) Cost Fair Value Due within one year $ 10,821 $ 10,823 Due between one and two years 16,000 16,014 Total $ 26,821 $ 26,837 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Earnings Per Share [Abstract] | |
Reconciles Shares to Calculate Basic and Diluted Net Income Per Share | The following schedule reconciles the shares used to calculate basic and diluted net income per share: Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, (In thousands) 2015 2014 2015 2014 Shares used in basic per share computation 26,597 26,938 26,644 27,018 Effect of dilutive common stock options outstanding 139 118 143 138 Effect of dilutive restricted stock units outstanding 532 592 563 622 Shares used in diluted per share computation 27,268 27,648 27,350 27,778 |
Supplemental Cash Flow Inform22
Supplemental Cash Flow Information (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Supplemental Cash Flow Information [Abstract] | |
Supplemental Disclosure of Cash Flow Information | The following is supplemental disclosure of cash flow information: Nine Months Ended October 2, October 3, (In thousands) 2015 2014 Cash paid during period: Income taxes $ 17,087 $ 17,458 Non-cash investing and financing activities: Unrealized (loss) gain on short-term investments $ (4) $ 9 Vested stock unit awards issued to settle accrued bonuses $ 6,169 $ 6,008 Accrual for capital expenditures $ 805 $ 164 Stock repurchases payable to broker $ - $ 1,551 |
Accounts Receivable, Net (Table
Accounts Receivable, Net (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Receivables [Abstract] | |
Accounts Receivable, Net | At October 2, 2015 and January 2, 2015, accounts receivable, net, was comprised of the following: October 2, January 2, (In thousands) 2015 2015 Billed accounts receivable $ 61,722 $ 63,331 Unbilled accounts receivable 35,786 26,423 Allowance for doubtful accounts and contract losses (3,340) (3,386) Total accounts receivable, net $ 94,168 $ 86,368 |
Segment Reporting (Tables)
Segment Reporting (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Disclosure Segment Information [Abstract] | |
Segment Reporting Information, by Segment | ation for the three and nine months ended October 2, 2015 and October 3, 2014 follows: Revenues Three Months Ended Nine Months Ended October 2, October 3, October 2, October 3, (In thousands) 2015 2014 2015 2014 Engineering and Other Scientific $ 61,052 $ 57,491 $ 180,212 $ 168,611 Environmental and Health 17,942 21,066 58,939 62,482 Total revenues $ 78,994 $ 78,557 $ 239,151 $ 231,093 Operating Income Three Months Ended Nine Months Ended (In thousands) October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Engineering and Other Scientific $ 20,252 $ 18,939 $ 58,605 $ 55,457 Environmental and Health 5,039 7,007 18,134 20,171 Total segment operating income 25,291 25,946 76,739 75,628 Corporate operating expense (4,370) (6,708) (22,085) (26,212) Total operating income $ 20,921 $ 19,238 $ 54,654 $ 49,416 Capital Expenditures Three Months Ended Nine Months Ended (In thousands) October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Engineering and Other Scientific $ 1,057 $ 1,509 $ 2,268 $ 2,833 Environmental and Health 52 36 123 151 Total segment capital expenditures 1,109 1,545 2,391 2,984 Corporate capital expenditures 1,532 385 1,964 922 Total capital expenditures $ 2,641 $ 1,930 $ 4,355 $ 3,906 Depreciation and Amortization Three Months Ended Nine Months Ended (In thousands) October 2, October 3, October 2, October 3, 2015 2014 2015 2014 Engineering and Other Scientific $ 951 $ 923 $ 2,877 $ 2,664 Environmental and Health 46 49 133 145 Total segment depreciation and amortization 997 972 3,010 2,809 Corporate depreciation and amortization 332 374 1,024 1,170 Total depreciation and amortization $ 1,329 $ 1,346 $ 4,034 $ 3,979 |
Goodwill (Tables)
Goodwill (Tables) | 9 Months Ended |
Oct. 02, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Breakdown of Goodwill Reported by Segment | Below is a breakdown of goodwill reported by segment as of October 2, 2015: Environmental Engineering and (In thousands) and Health Other Scientific Total Goodwill $ 8,099 $ 508 $ 8,607 |
Basis of Presentation - Additio
Basis of Presentation - Additional Information (Detail) - $ / shares | 1 Months Ended | |||
May. 28, 2015 | Oct. 21, 2015 | Oct. 02, 2015 | Jan. 02, 2015 | |
Authorized Capital Stock [Line Items] | ||||
Common stock, dividends per share declared, subsequent event | $ 0.15 | |||
Common Stock Shares Authorized | 80,000,000 | 80,000,000 | 80,000,000 | |
Preferred Stock, Shares Authorized | 2,000,000 | |||
Stockholders' Equity Note, Stock Split | two-for-one stock split |
Common Stock Dividends Declared
Common Stock Dividends Declared And Paid Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
Oct. 02, 2015 | Jul. 03, 2015 | Apr. 03, 2015 | Jan. 02, 2015 | Oct. 03, 2014 | Jul. 04, 2014 | Apr. 04, 2014 | Oct. 02, 2015 | Jan. 02, 2015 | |
Class of Stock [Line Items] | |||||||||
Dividends Per Share | $ 0.150 | $ 0.150 | $ 0.150 | $ 0.125 | $ 0.125 | $ 0.125 | $ 0.125 | ||
Amount | $ 3,870 | $ 3,887 | $ 3,858 | $ 3,216 | $ 3,262 | $ 3,270 | $ 3,262 | $ 11,615 | $ 13,010 |
Assets and Liabilities Measured
Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 | ||
Assets | ||||
Money market securities | $ 3,608 | [1] | $ 45,478 | [2] |
Total | 71,729 | 114,239 | ||
Liabilities | ||||
Deferred compensation plan | 45,038 | [3] | 45,394 | [4] |
Total | 45,038 | 45,394 | ||
Fixed income securities | ||||
Assets | ||||
Fixed income available-for-sale securities | 26,837 | [5] | 24,913 | [6] |
Fixed income trading securities held in deferred compensation plan | 9,007 | [7] | 9,672 | [8] |
Equity securities | ||||
Assets | ||||
Equity trading securities held in deferred compensation plan | 32,277 | [7] | 34,176 | [8] |
Fair Value, Inputs, Level 1 | ||||
Assets | ||||
Money market securities | 3,608 | [1] | 45,478 | [2] |
Total | 44,892 | [1] | 89,326 | [2] |
Liabilities | ||||
Deferred compensation plan | 45,038 | [1],[3] | 45,394 | [2],[4] |
Total | 45,038 | [1] | 45,394 | [2] |
Fair Value, Inputs, Level 1 | Fixed income securities | ||||
Assets | ||||
Fixed income available-for-sale securities | 0 | [1],[5] | 0 | [2],[6] |
Fixed income trading securities held in deferred compensation plan | 9,007 | [1],[7] | 9,672 | [2],[8] |
Fair Value, Inputs, Level 1 | Equity securities | ||||
Assets | ||||
Equity trading securities held in deferred compensation plan | 32,277 | [1],[7] | 34,176 | [2],[8] |
Fair Value, Inputs, Level 2 | ||||
Assets | ||||
Money market securities | 0 | [1],[5] | 0 | [2],[6] |
Total | 26,837 | [5] | 24,913 | [6] |
Liabilities | ||||
Deferred compensation plan | 0 | [3],[5] | 0 | [4],[6] |
Total | 0 | [5] | 0 | [6] |
Fair Value, Inputs, Level 2 | Fixed income securities | ||||
Assets | ||||
Fixed income available-for-sale securities | 26,837 | [5] | 24,913 | [6] |
Fixed income trading securities held in deferred compensation plan | 0 | [5],[7] | 0 | [6],[8] |
Fair Value, Inputs, Level 2 | Equity securities | ||||
Assets | ||||
Equity trading securities held in deferred compensation plan | 0 | [5],[7] | 0 | [6],[8] |
Fair Value, Inputs, Level 3 | ||||
Assets | ||||
Money market securities | 0 | [1],[7] | 0 | [2],[8] |
Total | 0 | [7] | 0 | [8] |
Liabilities | ||||
Deferred compensation plan | 0 | [3],[7] | 0 | [4],[8] |
Total | 0 | [7] | 0 | [8] |
Fair Value, Inputs, Level 3 | Fixed income securities | ||||
Assets | ||||
Fixed income available-for-sale securities | 0 | [5],[7] | 0 | [6],[8] |
Fixed income trading securities held in deferred compensation plan | 0 | [7] | 0 | [8] |
Fair Value, Inputs, Level 3 | Equity securities | ||||
Assets | ||||
Equity trading securities held in deferred compensation plan | $ 0 | [7] | $ 0 | [8] |
[1] | Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. | |||
[2] | Included in cash and cash equivalents on the Company’s consolidated balance sheet. | |||
[3] | Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet. | |||
[4] | Included in accrued payroll and employee benefits and deferred compensation on the Company’s consolidated balance sheet. | |||
[5] | Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. | |||
[6] | Included in short-term investments on the Company’s consolidated balance sheet. | |||
[7] | Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. | |||
[8] | Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s consolidated balance sheet. |
Cash, Cash Equivalents And Shor
Cash, Cash Equivalents And Short Term Investments (Detail) - USD ($) $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 |
Fair Value Measurements [Line Items] | ||
Amortized Cost | $ 151,278 | $ 154,380 |
Unrealized Gains | 17 | 27 |
Unrealized Losses | (1) | (4) |
Estimated Fair Value | 151,294 | 154,403 |
U.S. Agency Securities | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 16,000 | |
Unrealized Gains | 14 | |
Unrealized Losses | 0 | |
Estimated Fair Value | 16,014 | |
Cash | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 120,849 | 84,012 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Estimated Fair Value | 120,849 | 84,012 |
Money market securities | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 3,608 | 45,478 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Estimated Fair Value | 3,608 | 45,478 |
Total cash equivalents | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 3,608 | 45,478 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Estimated Fair Value | 3,608 | 45,478 |
Total cash and cash equivalents | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 124,457 | 129,490 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Estimated Fair Value | 124,457 | 129,490 |
State and municipal bonds | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 10,821 | 24,890 |
Unrealized Gains | 3 | 27 |
Unrealized Losses | (1) | (4) |
Estimated Fair Value | 10,823 | 24,913 |
Total short-term investments | ||
Fair Value Measurements [Line Items] | ||
Amortized Cost | 26,821 | 24,890 |
Unrealized Gains | 17 | 27 |
Unrealized Losses | (1) | (4) |
Estimated Fair Value | $ 26,837 | $ 24,913 |
Summarizes Cost And Estimated F
Summarizes Cost And Estimated Fair Value Of Short Term Fixed Income Securities (Detail) - USD ($) $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 |
Fair Value Measurements [Line Items] | ||
Due within one year, Amortized Cost | $ 10,821 | |
Due between one and two years, Amortized Cost | 16,000 | |
Total Amortized Cost | 26,821 | |
Due within one year, Estimated Fair Value | 10,823 | |
Due between one and two years, Estimated Fair Value | 16,014 | |
Total Estimated Fair Value | $ 26,837 | $ 24,913 |
Net Income Per Share - Addition
Net Income Per Share - Additional Information (Detail) - Employee Stock Option [Member] - $ / shares | 3 Months Ended | 9 Months Ended |
Oct. 02, 2015 | Oct. 02, 2015 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 40,000 | 33,993 |
Antidilutive Shares Weighted Average Exercise Price | $ 44.20 | $ 44.20 |
Reconciliation of Shares Used t
Reconciliation of Shares Used to Calculate Basic and Diluted Net Income Per Share (Detail) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | |
Schedule Of Earnings Per Share Basic and Diluted [Line Items] | ||||
Shares used in basic per share computation | 26,597 | 26,938 | 26,644 | 27,018 |
Shares used in diluted per share computation | 27,268 | 27,648 | 27,350 | 27,778 |
Employee Stock Option | ||||
Schedule Of Earnings Per Share Basic and Diluted [Line Items] | ||||
Effect of dilutive stock outstanding | 139 | 118 | 143 | 138 |
Restricted Stock Units (RSUs) | ||||
Schedule Of Earnings Per Share Basic and Diluted [Line Items] | ||||
Effect of dilutive stock outstanding | 532 | 592 | 563 | 622 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share Based Compensation Arrangement By Share Based Payment Award Options Expiration Term | 10 years | |||
Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Percentage of annual bonus settled with fully vested restricted stock unit awards | 40.00% | |||
Unvested Restricted Stock | Minimum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Recipient age to expense award on grant date | 59 years 6 months | |||
Employee Stock Option | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expense | $ 51,000 | $ 71,000 | $ 499,000 | $ 615,000 |
Vesting percentage of stock options granted per year | 25.00% | |||
Stock based compensation, vesting period | 4 years | |||
Vested Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expense | 1,616,000 | 1,657,000 | $ 4,959,000 | 4,825,000 |
Stock based compensation, holding period | 4 years | |||
Unvested Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expense | $ 967,000 | $ 982,000 | $ 5,078,000 | $ 5,145,000 |
Stock based compensation, vesting period | 4 years | |||
Unvested Stock Options | Minimum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Recipient age to expense award on grant date | 59 years 6 months |
Treasury Stock - Additional Inf
Treasury Stock - Additional Information (Detail) - USD ($) | 9 Months Ended | ||||
Oct. 02, 2015 | Oct. 03, 2014 | May. 29, 2014 | Feb. 15, 2013 | Feb. 09, 2012 | |
Equity, Class of Treasury Stock [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 35,000,000 | $ 35,000,000 | $ 35,000,000 | ||
Purchase of treasury shares (in shares) | 463,402 | 767,278 | |||
Repurchase of treasury shares | $ 19,814,000 | $ 27,923,000 | |||
Remaining authorized amount for repurchase of common stock | 15,265,000 | ||||
Treasury stock reissued at lower than repurchase price | $ 4,943,000 | $ 6,050,000 |
Deferred Compensation Plans - A
Deferred Compensation Plans - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | Jan. 02, 2015 | |
Deferred Compensation, Excluding Share-based Payments and Retirement Benefits | |||||
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] | |||||
Trading securities | $ 41,284,000 | $ 41,284,000 | $ 43,848,000 | ||
Deferred compensation plan vested amounts due | 45,038,000 | 45,038,000 | $ 45,394,000 | ||
Change in market value of trust assets | $ 2,688,000 | $ 1,331,000 | $ (1,379,000) | $ 1,351,000 | |
Maximum | |||||
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] | |||||
Percentage of compensation deferred | 100.00% |
Supplemental Disclosure of Cash
Supplemental Disclosure of Cash Flow Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | |
Cash paid during period: | ||||
Income taxes | $ 17,087 | $ 17,458 | ||
Non-cash investing and financing activities: | ||||
Unrealized (loss) gain on short-term investments | $ 13 | $ (13) | (4) | 9 |
Vested stock unit awards issued to settle accrued bonuses | 6,169 | 6,008 | ||
Accrual for capital expenditures | 805 | 164 | ||
Stock repurchases payable to broker | $ 0 | $ 1,551 |
Accounts Receivable, Net (Detai
Accounts Receivable, Net (Detail) - USD ($) $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Allowance for doubtful accounts and contract losses | $ (3,340) | $ (3,386) |
Total accounts receivable, net | 94,168 | 86,368 |
Unbilled accounts receivable | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Accounts receivable | 35,786 | 26,423 |
Billed accounts receivable | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Accounts receivable | $ 61,722 | $ 63,331 |
Segment Information (Detail)
Segment Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Oct. 02, 2015 | Oct. 03, 2014 | Oct. 02, 2015 | Oct. 03, 2014 | |
Segment Reporting Information [Line Items] | ||||
Revenues | $ 78,994 | $ 78,557 | $ 239,151 | $ 231,093 |
Operating Income | 20,921 | 19,238 | 54,654 | 49,416 |
Capital Expenditures | 2,641 | 1,930 | 4,355 | 3,906 |
Depreciation and Amortization | 1,329 | 1,346 | 4,034 | 3,979 |
Engineering and Other Scientific | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 61,052 | 57,491 | 180,212 | 168,611 |
Operating Income | 20,252 | 18,939 | 58,605 | 55,457 |
Capital Expenditures | 1,057 | 1,509 | 2,268 | 2,833 |
Depreciation and Amortization | 951 | 923 | 2,877 | 2,664 |
Environmental and Health | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 17,942 | 21,066 | 58,939 | 62,482 |
Operating Income | 5,039 | 7,007 | 18,134 | 20,171 |
Capital Expenditures | 52 | 36 | 123 | 151 |
Depreciation and Amortization | 46 | 49 | 133 | 145 |
Operating segments | ||||
Segment Reporting Information [Line Items] | ||||
Operating Income | 25,291 | 25,946 | 76,739 | 75,628 |
Capital Expenditures | 1,109 | 1,545 | 2,391 | 2,984 |
Depreciation and Amortization | 997 | 972 | 3,010 | 2,809 |
Corporate | ||||
Segment Reporting Information [Line Items] | ||||
Operating Income | (4,370) | (6,708) | (22,085) | (26,212) |
Capital Expenditures | 1,532 | 385 | 1,964 | 922 |
Depreciation and Amortization | $ 332 | $ 374 | $ 1,024 | $ 1,170 |
Segment Reporting - Additional
Segment Reporting - Additional Information (Detail) | 9 Months Ended | ||
Oct. 02, 2015 | Jan. 02, 2015 | Oct. 03, 2014 | |
Segment Reporting Information [Line Items] | |||
Number of Operating Segments | 2 | ||
Percentage of account receivable | 10.00% | 10.00% | |
Percentage of Company's revenue | 10.00% | 10.00% |
Breakdown of Goodwill Reported
Breakdown of Goodwill Reported by Segment (Detail) - USD ($) $ in Thousands | Oct. 02, 2015 | Jan. 02, 2015 |
Goodwill [Line Items] | ||
Goodwill | $ 8,607 | $ 8,607 |
Environmental and Health | ||
Goodwill [Line Items] | ||
Goodwill | 8,099 | |
Engineering and Other Scientific | ||
Goodwill [Line Items] | ||
Goodwill | $ 508 |
Goodwill - Additional Informati
Goodwill - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended |
Oct. 02, 2015 | Oct. 02, 2015 | |
Goodwill [Line Items] | ||
Goodwill, Acquisitions | $ 0 | $ 0 |
Goodwill, Dispositions | 0 | 0 |
Goodwill, Impairments or other change | 0 | 0 |
Goodwill, Changes in the composition | $ 0 | $ 0 |
Subsequent Event - Additional I
Subsequent Event - Additional Information (Detail) - USD ($) | Oct. 21, 2015 | Oct. 02, 2015 | May. 29, 2014 | Feb. 15, 2013 | Feb. 09, 2012 |
Subsequent Event [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 35,000,000 | $ 35,000,000 | $ 35,000,000 | ||
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $ 15,265,000 | ||||
Subsequent Event [Member] | |||||
Subsequent Event [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 35,000,000 | ||||
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $ 50,000,000 |